← Back to Search

Behavioral Intervention

Education and Navigation Program for Lupus (LEAP Trial)

N/A
Recruiting
Led By David H Chae, Sc.D., M.A.
Research Sponsored by Tulane University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years of age
Living with systemic lupus erythematosus (SLE)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

LEAP Trial Summary

This trial tests if an educational program can increase COVID testing/vaccination among people with lupus and their social networks.

Who is the study for?
This trial is for adults over 18 living with systemic lupus erythematosus (SLE) in metropolitan Birmingham, Alabama. Participants must be able to speak and understand English. Those without a confirmed SLE diagnosis, under 18, or living outside the specified area cannot join.Check my eligibility
What is being tested?
The study aims to compare the effectiveness of two approaches: one that provides only education about COVID-19 testing and vaccination, and another that includes navigation assistance to help people with SLE get tested or vaccinated against COVID-19.See study design
What are the potential side effects?
Since this trial focuses on education and navigation interventions rather than medical treatments, there are no direct side effects associated with drugs or medical procedures.

LEAP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have systemic lupus erythematosus (SLE).

LEAP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of COVID testing
Incidence of COVID-19 Vaccination

LEAP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: NavigationExperimental Treatment1 Intervention
COVID education for people with lupus and tailored guidance in vaccination and testing for COVID and making appointments.
Group II: EducationActive Control1 Intervention
COVID education for people with lupus.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Navigation
2013
Completed Phase 4
~3660

Find a Location

Who is running the clinical trial?

Louisiana State University Health Sciences Center in New OrleansOTHER
114 Previous Clinical Trials
43,701 Total Patients Enrolled
Tulane UniversityLead Sponsor
115 Previous Clinical Trials
226,002 Total Patients Enrolled
Xavier University of Louisiana.OTHER
6 Previous Clinical Trials
2,328 Total Patients Enrolled

Media Library

Vaccine Concierge (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05243875 — N/A
Lupus Research Study Groups: Navigation, Education
Lupus Clinical Trial 2023: Vaccine Concierge Highlights & Side Effects. Trial Name: NCT05243875 — N/A
Vaccine Concierge (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05243875 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any more participants being taken into this research trial?

"That is accurate. According to information provided on clinicaltrials.gov, this medical trial began recruiting participants on February 1st 2023 and will continue until 800 patients are recruited from a single research centre."

Answered by AI

What is the current enrollment for this research project?

"Right. Data hosted on clinicaltrials.gov confirms that this study, which was initially posted in February of 2023, is currently recruiting participants. In total, 800 people must be enrolled at one location."

Answered by AI
~333 spots leftby Apr 2025